Off-Label Drug Use in Oncology
The off-label use of medicines is a routine clinical practice of oncology, especially in malignant-tumour patients with no treatment alternatives left when registered-drug options have been exhausted or standard therapies reveal contraindications. The recent shift from single-gene assays to multigen...
Saved in:
| Main Authors: | E. V. Karabina, D. D. Sakaeva, O. N. Lipatov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2022-07-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01) -
Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01) -
Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01) -
Prescribing Drugs not in Accordance with the Official Instructions for Medical Use (Off-label), Clinical Guidelines, Standards of Medical Care and Legal Regulation in the Russian Federation. Part 2
by: A. R. Navasardyan, et al.
Published: (2021-05-01) -
Nanomaterials: breaking the bottleneck of breast cancer drug resistance
by: Chao Guan, et al.
Published: (2024-11-01)